Statute Details
- Title: MediShield Life Scheme (Disclosure of Information) Regulations 2017
- Act Code: MLSA2015-S458-2017
- Legislative Type: Subsidiary legislation (Regulations)
- Authorising Act: MediShield Life Scheme Act 2015 (Act 4 of 2015)
- Enacting Power: Section 34(1) of the MediShield Life Scheme Act 2015
- Citation: S 458/2017
- Commencement: 30 November 2017
- Maker: Permanent Secretary, Ministry of Health (Chan Heng Kee)
- Date Made: 11 August 2017
- Status: Current version as at 27 Mar 2026
- Key Provisions:
- Section 2: Prescribed public schemes for purposes of Part 5 of the Act are all healthcare-related public schemes.
- Section 3: Defines “healthcare-related public schemes” for purposes of Part 5 of the Act, including (a) all relevant public schemes and (b) public schemes established by Government/public authorities administered by MOH that provide specified grants/subsidies/benefits.
- Section 4: Revokes the 2015 disclosure regulations (G.N. No. S 526/2015).
What Is This Legislation About?
The MediShield Life Scheme (Disclosure of Information) Regulations 2017 (“Disclosure Regulations”) are subsidiary legislation made under the MediShield Life Scheme Act 2015. In plain terms, these Regulations identify which public healthcare-related schemes are treated as “prescribed public schemes” for the purposes of Part 5 of the MediShield Life Scheme Act 2015—specifically, the information-disclosure framework that allows certain parties to disclose and/or receive information in connection with MediShield Life.
Although the Regulations themselves are short, their legal effect is significant: they determine the scope of schemes that fall within the disclosure regime. This matters because disclosure provisions in the Act typically operate by reference to “prescribed public schemes”. By designating categories of public schemes, the Regulations control who may be involved in information sharing and for what kinds of healthcare-related financial support.
Practically, the Regulations ensure that MediShield Life information can be disclosed in a structured way to support the administration of other healthcare and disability-related public schemes—such as schemes that subsidise premiums for healthcare/disability insurance, fund domestic help and care for disabled or elderly persons, cover “step-down care” expenses, and provide other healthcare expenses.
What Are the Key Provisions?
Section 1 (Citation and commencement) provides the formal commencement date. The Regulations are cited as the MediShield Life Scheme (Disclosure of Information) Regulations 2017 and come into operation on 30 November 2017. For practitioners, this is relevant when assessing whether disclosure activities were authorised under the Regulations at a particular time, or whether earlier rules (including the revoked 2015 Regulations) applied.
Section 2 (Prescribed public schemes) sets the headline rule. It states that the “prescribed public schemes” for the purposes of Part 5 of the Act are all healthcare-related public schemes. This is a broad gateway provision: once a scheme qualifies as “healthcare-related”, it is automatically within the disclosure framework.
Section 3 (Healthcare-related public schemes) is the core definitional provision. It specifies two categories of schemes that qualify as “healthcare-related public schemes”:
(a) All relevant public schemes; and
(b) All public schemes established by the Government or a public authority, and administered by the Ministry of Health, that provide any grant, subsidy or other benefit for specified purposes.
Category (b) is further broken down into four types of benefits/expenses. The Regulations cover schemes that provide support for:
(i) Premiums for any healthcare or disability care insurance scheme;
(ii) Domestic help and care for disabled or elderly persons, or for devices and consumables used in the care of such persons;
(iii) Step-down care as defined in section 2(1) of the Medical and Elderly Care Endowment Schemes Act (Cap. 173A);
(iv) Other healthcare expenses.
From a legal interpretation standpoint, Section 3 is doing two things at once. First, it captures “relevant public schemes” (a term likely defined in the MediShield Life Scheme Act 2015 or elsewhere in the Act’s interpretive provisions). Second, it captures a defined set of MOH-administered Government/public authority schemes that provide particular types of financial support. The inclusion of “devices and consumables” and “domestic help and care” indicates that the disclosure regime is not limited to hospital or medical treatment costs; it extends to broader care-related support.
Section 4 (Revocation) revokes the earlier set of regulations: the MediShield Life Scheme (Prescribed Public Scheme for Disclosure of Information) Regulations 2015 (G.N. No. S 526/2015). This means that, from the commencement date of the 2017 Regulations, the 2015 disclosure designation rules no longer apply. For compliance and audit purposes, practitioners should ensure that internal policies and disclosure workflows reflect the current designation under the 2017 Regulations rather than relying on the revoked 2015 instrument.
How Is This Legislation Structured?
The Regulations are structured as a compact instrument with four sections:
Section 1 sets out the citation and commencement.
Section 2 identifies the class of schemes that are “prescribed public schemes” by reference to “healthcare-related public schemes”.
Section 3 defines what counts as “healthcare-related public schemes”, including both “relevant public schemes” and specified MOH-administered Government/public authority schemes that provide particular grants/subsidies/benefits.
Section 4 revokes the 2015 disclosure regulations.
Notably, the Regulations do not themselves set out the mechanics of disclosure (who may disclose, to whom, and for what purposes). Instead, they operate as a “designation” instrument—supplying the categories that Part 5 of the MediShield Life Scheme Act 2015 relies on.
Who Does This Legislation Apply To?
In scope, the Regulations apply to the extent that Part 5 of the MediShield Life Scheme Act 2015 governs disclosure of information involving MediShield Life. While the Regulations are addressed to the legal framework under the Act, the practical effect is on entities that administer or interact with the MediShield Life scheme and the designated public schemes.
Section 3(b) is particularly instructive: it focuses on public schemes established by the Government or a public authority and administered by the Ministry of Health. Therefore, the disclosure framework is designed to support MOH-administered healthcare-related public benefits. In addition, the inclusion of “all relevant public schemes” indicates that other public schemes within the Act’s defined universe may also be implicated.
Why Is This Legislation Important?
Although the Disclosure Regulations are brief, they are important because they determine the boundary of the information-sharing regime under the MediShield Life Scheme Act 2015. In healthcare administration, disclosure of personal data and claims-related information is often sensitive and tightly regulated. By specifying which public schemes are “prescribed”, the Regulations help ensure that disclosure is legally authorised only for schemes that fall within the healthcare-related categories.
From a practitioner’s perspective, the key compliance implication is that internal governance for disclosure must be aligned with the current designation. If a scheme is not within the categories in Section 3, it may fall outside the “prescribed public schemes” concept and therefore outside the Act’s Part 5 disclosure permissions (depending on how the Act structures disclosure). Conversely, if a scheme is within the categories—particularly MOH-administered schemes providing premium subsidies, care-related support, step-down care support, or other healthcare expenses—then disclosure workflows may be justified under the Act’s framework.
The revocation in Section 4 also matters for legal certainty. Practitioners should treat the 2017 Regulations as the controlling instrument for the designation of prescribed public schemes from its commencement date. Where disputes arise about whether disclosure was authorised at a particular time, the commencement date (30 November 2017) and the fact of revocation of the 2015 Regulations will be central.
Related Legislation
- MediShield Life Scheme Act 2015 (Act 4 of 2015) — authorising Act; Part 5 provides the disclosure framework referenced by these Regulations.
- Medical and Elderly Care Endowment Schemes Act (Cap. 173A) — referenced for the definition of “step-down care” in Section 3(iii).
- Shield Life Scheme Act 2015 — listed in the provided metadata as related legislation (relevant for historical context and scheme evolution).
- Elderly Care Endowment Schemes Act — listed in the provided metadata as related legislation (for broader context on elderly care support schemes).
- Timeline — for version control and amendment history (as referenced in the legislation interface).
Source Documents
This article provides an overview of the MediShield Life Scheme (Disclosure of Information) Regulations 2017 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.